Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 1, 2004, Pages 56-59

  Espinosa, Avelina ^a,c   Clark, David ^b   Stanley Jr , Samuel L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Alcohol dehydrogenase E; Bifunctional proteins; Cycloalkanols; Eukaryotic parasites; Glycolytic pathways

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ANTIAMEBIC AGENT; METHANOL DERIVATIVE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ENTAMOEBA HISTOLYTICA; ENZYME ACTIVITY; FERMENTATION; GIARDIA LAMBLIA; IC 50; IN VITRO STUDY; NONHUMAN; SURVIVAL RATE; TROPHOZOITE;

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIPROTOZOAL AGENTS; CYCLOBUTANES; CYCLOPROPANES; ENTAMOEBA HISTOLYTICA; ENZYME INHIBITORS; METHANOL; RECOMBINANT PROTEINS;

EID: 3543150722     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh280     Document Type: Article

References (25)

1. Walsh, J. A. (1988). Prevalence of Entamoeba histolytica infection. In Amoebiasis: Human Infection by Entamoeba histolytica (Ravdin, J. I., Ed.), pp. 93-105. Wiley Medical, New York, NY, USA.
2. Walsh, J. A. (1986). Problems in recognition and diagnosis of amoebiasis: estimation of the global magnitude of morbidity and mortality. Reviews in Infectious Diseases 8, 228-38.
3. Goldman, P., Koch, R. L., Yeung, T. C. et al. (1986). Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity. Biochemical Pharmacology 35, 43-51.
4. Knight, R. C., Skolioowski, I. M. & Edwards, D. I. (1978). The interaction of reduced metronidazole with DNA. Biochemical Pharmacology 27, 2089-93.
5. Koch, C. J., Lord, E. M., Shapiro, I. M. et al. (1997). Imaging hypoxia and blood flow in normal tissues. Advances in Experimental Medicine and Biology 428, 585-93.
6. Kock, R. L., Beaulieu, B. B., Jr, Chrystal, E. J. T. et al. (1981). A metronidazole metabolite in human urine and its risk. Science 211, 398-400.
7. Reeves, R. E. (1984). Metabolism of Entamoeba histolytica Schaudinn, 1903. Advances in Parasitology 23, 105-42.
8. Lo, H. & Reeves, R. E. (1978). Pyruvate-to-ethanol pathway in Entamoeba histolytica. Biochemical Journal 171, 225-30.
9. Yang, W., Li, E., Kairong, T. et al. (1994). Entamoeba histolytica has an alcohol dehydrogenase homologous to the adhE gene product of Escherichia coli. Molecular and Biochemical Parasitology 64, 253-60.
10. Espinosa, A., Wang, L., Li, E. et al. (1997). Expression of the alcohol dehydrogenase (ADH) domain of Entamoeba histolytica EhADH2 enzyme. Archives of Medical Research 28, S78-81.
11. Espinosa, A., Yang, L., Zhang, Z. et al. (2001). The bifunctional Entamoeba histolytica 2 (EhADH2) protein is necessary for amoebic growth and survival and requires an intact C-terminal domain for both alcohol dehydrogenase and aldehyde dehydrogenase activity. Journal of Biological Chemistry 276, 20136-43.
12. Goodlove, P. E., Cunningham, P. R., Parker, J. et al. (1989). Cloning and sequence analysis of the fermentative alcohol-dehydrogenase-encoding gene of Escherichia coli. Gene 85, 209-14.
13. Yong, T., Li, E., Clark, D. et al. (1996). Complementation of an Escherichia coli adhE mutant by the Entamoeba histolytica EhADH2 gene provides a method for the identification of new anti-amoebic drugs. Proceedings of the National Academy of Sciences, USA 93, 6464-9.
14. Kessler, D., Herth, W. & Knappe, J. (1992). Ultrastructure and pyruvate formate-lyase radical quenching property of the multienzymic AdhE protein of Escherichia coli. Journal of Biological Chemistry 267, 18073-9.
15. Kessler, D., Leibrecht, I. & Knappe, J. (1991). Pyruvate-formate-lyase-deactivase and acetyl-CoA reductase activities of Escherichia coli reside on a polymeric protein particle encoded by adhE FEBS Letters 281, 59-63.
16. Reid, M. F. & Fewson, C. A. (1994). Molecular characterization of microbial alcohol dehydrogenases. Critical Reviews in Microbiology 20, 13-56.
17. Samuelson, J. (1999). Why metronidazole is active against both bacteria and parasites. Antimicrobial Agents and Chemotherapy 43, 1533-41.
18. LaBella, F. S., Chen, Q. M., Stein, D. et al. (1997). The site of general anesthesia and cytochrome P450 oxygenases: similarities defined by straight chain and cyclic alcohols. British Journal of Pharmacology 120, 1158-64.
19. Lancaster, F. E. (1992). Alcohol, nitric oxide, and neurotoxicity: is there a connection? A review. Alcohol Clinical & Experimental Research 6, 539-41.
20. Sherry, B. & Abeles, R. H. (1985). Mechanism of action of methanol oxidase, reconstitution of methanol oxidase with 5-deazaflavin, and inactivation of methanol oxidase by cyclopropanol. Biochemistry 24, 2594-605.
21. Nilsson, G. E. & Tottmar, O. (1987). Effects of biogenic aldehydes and aldehyde dehydrogenase inhibitors on rat brain tryptophan hydrolase activity in vitro. Brain Research 409, 374-9.
22. Wood, S. C., Hill, W. A. & Miller, K. W. (1993). Cycloalkane-methanols discriminate between volume- and length-dependent loss of activity of alkanols at the torpedo nicotinic acetylcholine receptor. Molecular Pharmacology 44, 1219-26.
23. Raines, D. E., Claycomb, R. J., Scheller, M. et al. (2001). Nonhalogenated alkane anesthetics fail to potentiate agonistic actions on two ligand-gated ion channels. Anesthesiology 95, 470-7.
24. Gingell, R., Regnier, J. F., Wilson, D. M. et al. (2003). Comparative metabolism of methyl isobutyl carbinol and methyl isobutyl ketone in male rats. Toxicology Letters 136, 199-204.
25. Wang, D. M. (2000). Role of alcohol dehydrogenase E (ADHE) in the energy metabolism of Giardia lamblia. Molecular and Biochemical Parasitology 109, 25-36.